Coexpression of CCR6 and CD146 (MCAM) is a marker of effector memory T-helper 17 cells

Journal of Dermatology

Volumn 39, Issue 10, 2012, Pages 838-842

  Kamiyama, Taisuke ^a   Watanabe, Hideaki ^a   Iijima, Masafumi ^a   Miyazaki, Akira ^a   Iwamoto, Sanju ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CCR6; CD146; effector memory T cell; psoriasis; Th17

Indexed keywords

BIOLOGICAL MARKER; CD146 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PSORIASIS VULGARIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

AGED; ANTIGENS, CD146; ANTIGENS, CD28; ANTIGENS, CD3; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-17; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, CCR6; RECEPTORS, CCR7; SEVERITY OF ILLNESS INDEX; TH17 CELLS;

EID: 84867103446     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01544.x     Document Type: Article

References (49)

1. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A,. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
2. Sallusto F, Geginat J, Lanzavecchia A,. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22: 745-763.
3. Cyster JG,. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005; 23: 127-159.
4. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
5. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
6. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-240.
7. Miossec P, Korn T, Kuchroo VK,. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898.
8. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T,. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000; 165: 6107-6115.
9. Rudner XL, Happel KI, Young EA, Shellito JE,. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007; 75: 3055-3061.
10. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748.
11. Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198: 1951-1957.
12. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116: 1310-1316.
13. Takagi R, Higashi T, Hashimoto K, et al. B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J Immunol 2008; 181: 186-189.
14. Santarlasci V, Maggi L, Capone M, et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol 2009; 39: 207-215.
15. Brucklacher-Waldert V, Steinbach K, Lioznov M, Kolster M, Holscher C, Tolosa E,. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. J Immunol 2009; 183: 5494-5501.
16. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-646.
17. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-1861.
18. Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180: 7423-7430.
19. Liu H, Rohowsky-Kochan C,. Regulation of IL-17 in human CCR6+ effector memory T cells. J Immunol 2008; 180: 7948-7957.
20. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM,. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 2008; 180: 214-221.
21. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A,. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010; 130: 1373-1383.
22. Lehmann JM, Riethmuller G, Johnson JP,. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 1989; 86: 9891-9895.
23. Sers C, Kirsch K, Rothbacher U, Riethmuller G, Johnson JP,. Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci USA 1993; 90: 8514-8518.
24. Shih IM, Elder DE, Speicher D, Johnson JP, Herlyn M,. Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 1994; 54: 2514-2520.
25. Bardin N, Frances V, Lesaule G, Horschowski N, George F, Sampol J,. Identification of the S-Endo 1 endothelial-associated antigen. Biochem Biophys Res Commun 1996; 218: 210-216.
26. Pickl WF, Majdic O, Fischer GF, et al. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 1997; 158: 2107-2115.
27. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr,. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005; 106: 2923-2924.
28. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E,. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009; 132: 3329-3341.
29. Elshal MF, Khan SS, Raghavachari N, et al. A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile. BMC Immunol 2007; 8: 29.
30. Lim HW, Lee J, Hillsamer P, Kim CH,. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3 + regulatory T cells. J Immunol 2008; 180: 122-129.
31. Crome SQ, Clive B, Wang AY, et al. Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J Immunol 2010; 185: 3199-3208.
32. Mehling M, Lindberg R, Raulf F, et al. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology 2010; 75: 403-410.
33. Cosmi L, De Palma R, Santarlasci V, et al. Human interleukin 17-producing cells originate from a CD161 + CD4 + T cell precursor. J Exp Med 2008; 205: 1903-1916.
34. Takahashi T, Dejbakhsh-Jones S, Strober S,. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 2006; 176: 211-216.
35. Dagur PK, Tatlici G, Gourley M, et al. CD146 + T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profiles. Cytometry B Clin Cytom 2010; 78: 88-95.
36. Dagur PK, Biancotto A, Wei L, et al. MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. J Autoimmun 2011; 37:: 319-327.
37. Gilhar A, David M, Ullmann Y, Berkutski T, Kalish RS,. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J Invest Dermatol 1997; 109: 283-288.
38. Krueger JG,. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46: 1-23. quiz -6.
39. Baker BS, Swain AF, Valdimarsson H, Fry L,. T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol 1984; 110: 37-44.
40. Gottlieb A, Krueger JG, Bright R, et al. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 2000; 42: 428-435.
41. Gordon KB, Papp KA, Hamilton TK, et al. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA 2003; 290: 3073-3080.
42. Chan JR, Blumenschein W, Murphy E, et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 2006; 203: 2577-2587.
43. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950-957.
44. Zaba LC, Cardinale I, Gilleaudeau P, et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007; 204: 3183-3194.
45. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-1211.
46. Harper EG, Guo C, Rizzo H, et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 2009; 129: 2175-2183.
47. Guezguez B, Vigneron P, Lamerant N, Kieda C, Jaffredo T, Dunon D,. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J Immunol 2007; 179: 6673-6685.
48. Yamazaki T, Yang XO, Chung Y, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 2008; 181: 8391-8401.
49. Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC,. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 2011; 20: 544-549.